Chronic fatigue syndrome: Update on diagnosis and treatment

Consultant

Volumn 40, Issue 8, 2000, Pages 1441-1450

  Khouzam, Hani Raoul ^a,b,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Manchester VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMANTADINE; AMPLIGEN; ANTIALLERGIC AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CHOLINESTERASE INHIBITOR; CYCLOBENZAPRINE; HYPNOTIC SEDATIVE AGENT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERLEUKIN 2; KUTAPRESSIN; METHISOPRINOL; METHOCARBAMOL; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM;

ARTICLE; BEHAVIOR THERAPY; CHRONIC FATIGUE SYNDROME; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; KINESIOTHERAPY; MENTAL DISEASE; MENTAL HEALTH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SELF HELP; SOCIAL DISABILITY; WORK DISABILITY;

EID: 0033853244     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wessely S. Chronic fatigue syndrome - the current position, I: background, epidemiology and aetiology. Prim Care Psychiatry. 1995;1:21-30.
2. Wilson A, Hickie I, Lloyd AR, et al. Longitudinal study of the outcome of chronic fatigue syndrome. BMJ. 1994;308:756-760.
3. Fukuda K, Strauss E, Hickie I, et al. Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953-959.
4. Tobi M, Morag A, Ravid Z, et al. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet. 1982;1:61-64.
5. Dubois RE, Seely JK, Bros I, et al. Chronic mononudeosis syndrome. South Med J. 1984;77: 1376-1382.
6. Klonoff DC. Chronic fatigue syndrome. Clin Infect Dis. 1992;15:812-823.
7. Shafran SD. The chronic fatigue syndrome. Am J Med. 1991;90:730-739.
8. Holmes GP, Kaplan JE, Grantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988;108:387-389.
9. Lewis G, Wessely S. The epidemiology of fatigue: more questions than answers. J Epidemiol Community Health. 1992;46:92-97.
10. McDonald E, David A, Pelosi A, Mann A. Chronic fatigue in general practice attendees. Psychol Med. 1993;23:987-998.
11. Walker EA, Katon WJ, Jemelka RP. Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J Gen Intern Med. 1993;8:436-440.
12. Ware NC. Sociosomatics and illness course in chronic fatigue syndrome. Psychosom Med. 1998;60: 394-401.
13. Gunn W, Connell D. Randall B. Epidemiology of chronic fatigue syndrome: the Centers for Disease Control study. In: Straus S, Kleirunan A, eds. Chronic Fatigue Syndrome. CIBA Foundation Symposium 173. Chichester, England: Wiley; 1993:83-101.
14. Lloyd A, Hickie I, Boughton C, et al. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust. 1990;152:522-528.
15. Ho-Yen D, McNamara I. General practitioners' experience of the chronic fatigue syndrome. Br J Gen Pract. 1991;41:324-326.
16. Price RK, North CS, Wessely S, Fraser VJ. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep. 1992;107:514-522.
17. Bleijemberg G, Vercoulen JHHM, Bazelmans E, et al. Natural course of CFS and its predictors. J Chronic Fatigue Syndrome. 1996;2:131.
18. Lane TJ, Matthews DA, Mann P. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci. 1990;297:313-318.
19. Calabrese L, Danao T, Camara E, Wilke W. Chronic fatigue syndrome. Am Fam Physician. 1992;45:1205-1213.
20. Kang HK, Bulman TA Mortality among U.S. veterans of the Persian Gulf war. N Engl J Med. 1996;335:1498-1504.
21. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994.
22. Siraus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial. N Engl J Med. 1988;26:1692-1698.
23. Block SR Fibromyalgia and the rheumatisms: common sense and sensibility. Rheum Dis Clin North Am. 1993;19:61-76.
24. Rozenberg GA, Appenzellero D. Amantadine, fatigue, and multiple sclerosis. Arch Neurol. 1988; 45:1104-1106.
25. David A, McDonald E, Mann A, et al Tired, weak or in need of rest: fatigue among general practice attendees. BMJ. 1990;301:1199-1202.
26. DeMeirfeir K. A review of the use of antiviral and immunomodulating drugs in the treatment of chronic fatigue syndrome. J Chronic Fatigue Syndrome. 1996;2:127-128.
27. Lloyd A, Hickie I, Wakefield D, et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med. 1990;89:561-568.
28. Straus SE. Intravenous immunoglobulin treatment for the chronic fatigue syndrome. Am J Med. 1990;89:551-553.
29. Gold D, Bowden R, Sixbey J, et al. Chronic fatigue: a prospective clinical and virologic study. JAMA. 1990;264:48-53.
30. McBride SJ, McCloskey DR Treatment of chronic fatigue syndrome. BMJ. 1991;47:895-907.
31. Kendell R. Chronic fatigue, viruses, and depression, Lancet. 1991;337:160-162.
32. Manu P, Matthews DA, Lane TJ. The mental health of patients with a chief complaint of chronic fatigue: a prospective evaluation and follow-up. Arch Intern Med. 1988;148:2213-2217.
33. Goodnick PJ, Sandsval R, Brickman A, Kilmas NG. Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. Biol Psychiatry. 1992;32: 834-838.
34. Satterthwaite JR, Tollison CD, Kriegel ML. The use of tricyclic antidepressants for the treatment of intractable pain. Compr Ther. 1990;16:10-15.
35. Quimby LG, Gratwick GM, Whitney CD, Block SR. A randomized trial of cydobenzapine for the treatment of fibromyalgia. J Rheumatol. 1998; 19(suppl):140-143.
36. Straus SE, Dale J, Wright R, Metcalfe D. Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol. 1988;81:791-795.
37. Olson GB, Kansan MN, Gersuk GM, et al. Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients. J Allergy Clin Immunol. 1986;78: 308-314.
38. Manu P, Matthews D, Lane T. Food intolerance in patients with chronic fatigue. Int J Eat Disord. 1993;13:203-209.
39. Snorrason E, Geirsson A, Stefanson K. Trial of a selective acetyl cholinesterase inhibitor, galanthamine hydrobromide, in the treatment of chronic fatigue syndrome. J Chronic Fatigue Syndrome. 1996;2:35-54.
40. Kroenke K, Wood DO, Mangelsdorff AD, et al. Chronic fatigue in primary care: prevalence, patient characteristics, and outcome. JAMA. 1989;260: 929-934.
41. Cinque C. Fibromyalgia: is exercise the cause or the cure? Physician Sports Med. 1989;17:181-184.
42. Schuyler DA Practical Guide to Cognitive Therapy. New York: WW Norton; 1991.
43. Butler S, Chadler T, Ron M, Wessely S. Cognitive therapy in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 1991;54:153-158.